Brand

DRIADA

Package

10 ml vial (250 mg/ml)

ANDRIOLOS 250 mg is a product name associated with Driada Medical and testosterone undecanoate, an esterified form of testosterone. Available laboratory documentation identifies ANDRIOLOS as a testosterone undecanoate product labeled at 250 mg/mL. However, laboratory testing of one batch does not independently verify the authenticity, quality, composition, or regulatory status of every package sold under the same name. Therefore, customers researching ANDRIOLOS should compare the current packaging, batch information, manufacturer details, and applicable regulatory documentation.

ANDRIOLOS 250 mg Product Details

Available testing information identifies ANDRIOLOS with a stated concentration of 250 mg/mL. A 2022 laboratory report for batch 062435 measured 250.39 mg/mL of testosterone undecanoate. Importantly, that result applies to the specific sample tested and should not automatically represent other batches or packages.

When reviewing ANDRIOLOS 250 mg, check the active ingredient, stated concentration, container volume, lot number, expiration date, manufacturer, packaging, and country of origin. Furthermore, compare those details with reliable pharmaceutical references instead of relying only on commercial product descriptions or individual laboratory reports.

Product Specifications

• Product name: ANDRIOLOS 250 mg
• Listed manufacturer: Driada Medical
• Active ingredient: Testosterone undecanoate
• Listed concentration: 250 mg/mL
• Product form: Injectable solution
• Product category: Testosterone/androgen
• Package quantity: Verify from current packaging
• Container volume: Verify from current packaging
• Regulatory status: Verify for your jurisdiction

Testosterone Undecanoate Information

Testosterone undecanoate is an ester of testosterone used in prescription testosterone medicines. It differs chemically from testosterone cypionate and testosterone enanthate, so products containing different testosterone esters should not automatically be considered interchangeable.

Official pharmaceutical documentation also confirms that testosterone undecanoate appears in both oral and injectable medicines, depending on the product and market. For example, approved Andriol Testocaps contain 40 mg testosterone undecanoate per capsule, while injectable products such as NEBIDO use a different presentation and concentration. Therefore, customers should distinguish ANDRIOLOS 250 mg from these separately authorized products.

For product information, customers can review Iron Elite Nutrition and compare the listing with authoritative pharmaceutical references. Moreover, the current product label should remain the primary reference for the exact ingredient, concentration, manufacturer, batch number, expiration date, and presentation.

Regulatory Considerations

Testosterone-containing medicines can be prescription products and may also fall under controlled-substance regulations depending on the jurisdiction. Consequently, legal requirements can apply to prescribing, dispensing, possession, importation, distribution, and sale. Requirements vary between countries and may change over time.

This description is intended for product identification and general research. It does not provide dosing schedules, injection instructions, cycle planning, or recommendations for non-prescribed use. For medical questions, consult a qualified healthcare professional who can evaluate the appropriate clinical context.

Sports and Anti-Doping Information

Athletes should also consider anti-doping requirements when researching testosterone products. Testosterone and its esters are included within the anabolic androgenic steroid category prohibited by the World Anti-Doping Agency. Therefore, competitive athletes should review the current WADA Prohibited List and their sporting organization’s rules before using any testosterone-containing product.

Overall, ANDRIOLOS 250 mg can be researched through its stated testosterone undecanoate identity, 250 mg/mL concentration, manufacturer information, packaging, batch details, and applicable regulatory requirements. Moreover, independent laboratory information can provide useful evidence about a particular tested sample, but it cannot independently authenticate every package or production batch.

Before making any product-related decision, review the original packaging, lot information, expiration date, manufacturer details, complete ingredient statement, and applicable local requirements. Likewise, keep the exact product label available when consulting a healthcare professional or checking official regulatory sources. This approach provides a clearer basis for evaluating ANDRIOLOS 250 mg without assuming that its product name, advertised concentration, or a single laboratory result independently proves authenticity, quality, regulatory approval, or suitability for personal use